7-CHLORO-3,4-DIHYDRO-2-(1-HYDROXYETHYL)-3-METHYL-4-OXO-6-QUINAZOLINESULFONAMIDE, (+/-)-
UNII S4VW0GAA5S
Substance Identification & Data
This profile provides standardized clinical and technical data for 7-chloro-3,4-dihydro-2-(1-hydroxyethyl)-3-methyl-4-oxo-6-quinazolinesulfonamide, (+/-)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S4VW0GAA5S.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 14422-45-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C11H12ClN3O4S IGLKJVXDXYQOKE-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 7-chloro-3,4-dihydro-2-(1-hydroxyethyl)-3-methyl-4-oxo-6-quinazolinesulfonamide, (+/-)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.